Nigeria Approves R21 Malaria Vaccine

today04/17/2023 6

share close

The National Agency for Food and Drug Administration and Control, NAFDAC, has approved the R21 malaria vaccine manufactured by the Serum Institute of India.

Director General of the Agency, Mojisola Adeyeye, said the vaccine is indicated for the prevention of clinical malaria in children from 5 months to 36 months of age.

Adeyeye noted that the country expects to get at least 100,000 doses of the vaccine in donations soon before the market authorisation will start making other arrangements.

This makes Nigeria the second country to approve the new malaria vaccine developed at the University of Oxford, after Ghana.

Written by: Helen Obih

Rate it

Previous post


APGA Condemns Attack on Delegates

The All Progressives Grand Alliance, APGA, has condemned the attack on its delegates and officials in the Imo State Governorship primary held last weekend in Owerri. This was disclosed in a statement National Publicity Secretary of the party, Tex Okechukwu, disclosed this in a statement on Monday. Okechukwu, who felt dissatisfied about the attack noted that the political space in the state is gradually being turned into a battlefield by […]

today04/17/2023 6

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

Our customer support team is here to answer your questions.
error: Alert: Content is protected !!